Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 1
2006 1
2007 2
2008 1
2009 6
2010 2
2011 5
2012 7
2013 9
2014 5
2015 6
2016 8
2017 8
2018 8
2019 15
2020 10
2021 6
2022 8
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells.
Anadon CM, Yu X, Hänggi K, Biswas S, Chaurio RA, Martin A, Payne KK, Mandal G, Innamarato P, Harro CM, Mine JA, Sprenger KB, Cortina C, Powers JJ, Costich TL, Perez BA, Gatenbee CD, Prabhakaran S, Marchion D, Heemskerk MHM, Curiel TJ, Anderson AR, Wenham RM, Rodriguez PC, Conejo-Garcia JR. Anadon CM, et al. Among authors: wenham rm. Cancer Cell. 2022 May 9;40(5):545-557.e13. doi: 10.1016/j.ccell.2022.03.008. Epub 2022 Apr 14. Cancer Cell. 2022. PMID: 35427494 Free PMC article.
IgA transcytosis and antigen recognition govern ovarian cancer immunity.
Biswas S, Mandal G, Payne KK, Anadon CM, Gatenbee CD, Chaurio RA, Costich TL, Moran C, Harro CM, Rigolizzo KE, Mine JA, Trillo-Tinoco J, Sasamoto N, Terry KL, Marchion D, Buras A, Wenham RM, Yu X, Townsend MK, Tworoger SS, Rodriguez PC, Anderson AR, Conejo-Garcia JR. Biswas S, et al. Among authors: wenham rm. Nature. 2021 Mar;591(7850):464-470. doi: 10.1038/s41586-020-03144-0. Epub 2021 Feb 3. Nature. 2021. PMID: 33536615 Free PMC article.
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).
Tanyi JL, Randall LM, Chambers SK, Butler KA, Winer IS, Langstraat CL, Han ES, Vahrmeijer AL, Chon HS, Morgan MA, Powell MA, Tseng JH, Lopez AS, Wenham RM. Tanyi JL, et al. Among authors: wenham rm. J Clin Oncol. 2023 Jan 10;41(2):276-284. doi: 10.1200/JCO.22.00291. Epub 2022 Sep 7. J Clin Oncol. 2023. PMID: 36070540 Clinical Trial.
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, Waters J, Berek JS, Woie K, Oza AM, Canzler U, Gil-Martin M, Lesoin A, Monk BJ, Lund B, Gilbert L, Wenham RM, Benigno B, Arora S, Hazard SJ, Mirza MR. Del Campo JM, et al. Among authors: wenham rm. J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173551 Free PMC article. Clinical Trial.
Surgical prevention strategies in ovarian cancer.
Mallen A, Soong TR, Townsend MK, Wenham RM, Crum CP, Tworoger SS. Mallen A, et al. Among authors: wenham rm. Gynecol Oncol. 2018 Oct;151(1):166-175. doi: 10.1016/j.ygyno.2018.08.005. Epub 2018 Aug 4. Gynecol Oncol. 2018. PMID: 30087058 Review.
Ovarian cancer: a bright future.
Wenham RM. Wenham RM. Cancer Control. 2011 Jan;18(1):4-5. doi: 10.1177/107327481101800101. Cancer Control. 2011. PMID: 21273974 Free article. No abstract available.
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Praiss AM, Miller A, Smith J, Lichtman SM, Bookman M, Aghajanian C, Sabbatini P, Backes F, Cohn DE, Argenta P, Friedlander M, Goodheart MJ, Mutch DG, Gershenson DM, Tewari KS, Wenham RM, Wahner Hendrickson AE, Lee RB, Gray H, Secord AA, Van Le L, O'Cearbhaill RE. Praiss AM, et al. Among authors: wenham rm. Gynecol Oncol. 2023 Jul;174:213-223. doi: 10.1016/j.ygyno.2023.05.013. Epub 2023 May 23. Gynecol Oncol. 2023. PMID: 37229879 Clinical Trial.
Implementing personalized medicine in a cancer center.
Fenstermacher DA, Wenham RM, Rollison DE, Dalton WS. Fenstermacher DA, et al. Among authors: wenham rm. Cancer J. 2011 Nov-Dec;17(6):528-36. doi: 10.1097/PPO.0b013e318238216e. Cancer J. 2011. PMID: 22157297 Free PMC article. Review.
New therapies for advanced, recurrent, and metastatic endometrial cancers.
Makker V, Green AK, Wenham RM, Mutch D, Davidson B, Miller DS. Makker V, et al. Among authors: wenham rm. Gynecol Oncol Res Pract. 2017 Dec 2;4:19. doi: 10.1186/s40661-017-0056-7. eCollection 2017. Gynecol Oncol Res Pract. 2017. PMID: 29214032 Free PMC article. Review.
Molecular aspects of ovarian cancer.
Wenham RM, Lancaster JM, Berchuck A. Wenham RM, et al. Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):483-97. doi: 10.1053/beog.2002.0298. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12413930 Review.
108 results